跳至主要内容
临床试验/ACTRN12613000646741
ACTRN12613000646741尚未招募2 期

PREPaRE study. A pilot study of corticosteroid and antihistamine premedication to prevent hypersensitivity reactions in patients receiving second (or subsequent) line treatment with Carboplatin for treatment of gynaecological malignancy

The Royal Women's Hospital0 个研究点目标入组 46 人开始时间: 2013年6月7日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Age 18 years and above
  • Histologically confirmed gynaecological malignancy
  • Commencing a carboplatin-containing regimen (this may include other chemo agents)
  • At least 1 prior line of carboplatin containing therapy
  • Performance status less than or equal to 2
  • Neutrophil count greater than or equal to 1.5 x 109/L, Platelet count greater than or equal to 100 x 109/L
  • Ability to record symptoms in patient diary
  • Written informed consent

排除标准

  • History of platinum HSR
  • Uncontrolled concurrent illness
  • Diabetes Mellitus requiring insulin
  • Pregnancy / lactation

研究者

发起方
The Royal Women's Hospital

相似试验